Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vincristine-induced neuropathy. A clinical study of fifty leukemic patients.

× No keyword cloud information.

65 in total

1. Prolonged gastrointestinal dysmotility in a patient with hemophagocytic lymphohistiocytosis treated with vincristine.

Authors: T Tomomasa; R Miyazawa; M Kato; M Hoshino; M Tabata; H Kaneko; M Suzuki; T Kobayashi; A Morikawa
Journal: Dig Dis Sci Date: 1999-09 Impact factor: 3.199

2. Vincristine-induced autonomic neuropathy.

Authors: B W Hancock; A Naysmith
Journal: Br Med J Date: 1975-07-26

3. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate.

Authors: F M Boyle; H R Wheeler; G M Shenfield
Journal: J Neurooncol Date: 1999-01 Impact factor: 4.130

4. Partially reversible nerve deafness due to vincristine.

Authors: H Yousif; S G Richardson; W A Saunders
Journal: Postgrad Med J Date: 1990-08 Impact factor: 2.401

Review 5. Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors: Julienne E Bower; Donald M Lamkin
Journal: Brain Behav Immun Date: 2012-07-06 Impact factor: 7.217

6. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.

Authors: E J Rahn; A Makriyannis; A G Hohmann
Journal: Br J Pharmacol Date: 2007-06-18 Impact factor: 8.739

Vincristine-induced neuropathy. A clinical study of fifty leukemic patients.

1. Prolonged gastrointestinal dysmotility in a patient with hemophagocytic lymphohistiocytosis treated with vincristine.

2. Vincristine-induced autonomic neuropathy.

3. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate.

4. Partially reversible nerve deafness due to vincristine.

Review 5. Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

6. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.

Review 7. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

8. Vindesine. A clinical trial with special reference to neurological side effects.

9. Can severe vincristine neurotoxicity be prevented?

10. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.